Status:
UNKNOWN
ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC
Lead Sponsor:
Shanghai Chest Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study is designed as a prospective trial whose purpose is to evaluate the effectiveness and safety of ENB-guided ablation therapy combined with VATS in the treatment of multiple primary lung cance...
Detailed Description
Patients will be first screened, and only after meeting all the selection criteria, not meeting any exclusion criteria, and signing the informed consent, could they be enrolled in the group to receive...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old.
- The subject is diagnosed as multiple primary lung cancer via preoperative imaging/pathological examination.
- Thin-slice CT images show that the ablation Lesion A is accessible/adjacent to bronchi and the size is ≤ 3 cm.
- The subject with multiple primary lung cancers can be treated with ENB-guided ablation therapy combined with VATS according to multidisciplinary assessment.
Exclusion
- The subject who cannot tolerate general anesthesia for their cardiopulmonary function, or there are other contraindications, such as uncorrectable coagulopathy.
- The situation in which the investigators think that the subject is not suitable to participate in this study.
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04730453
Start Date
July 24 2020
End Date
December 1 2025
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China, 200030